Skip to Content

APO M250 (Mycophenolate Mofetil 250 mg)

Pill with imprint APO M250 is Blue & Pink, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Apotex Corp..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO M250

Mycophenolate mofetil 250 mg APO M250
Mycophenolate mofetil 250 mg APO M250 Front
Mycophenolate mofetil 250 mg APO M250 Back
Mycophenolate mofetil 250 mg APO M250

Mycophenolate Mofetil

APO M250
250 mg
Blue & Pink
19.00 mm
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Inactive Ingredients
croscarmellose sodium, magnesium stearate, gelatin, sodium lauryl sulfate, ferric oxide red, titanium dioxide, indigotindisulfonate sodium, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, ferrosoferric oxide, potassium hydroxide, water

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
60505-2968 Apotex Corp.
68084-0587 Amerisource Health Services

Get help with Imprint Code FAQs.

Related Images for "APO M250"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.